Your browser doesn't support javascript.
loading
Alanine transaminase is predominantly increased in the active phase of anti-HMGCR myopathy.
Kubota, Akatsuki; Shimizu, Jun; Unuma, Atsushi; Maeda, Meiko; Shirota, Yuichiro; Kadoya, Masato; Uchio, Naohiro; Sakiyama, Yoshio; Arai, Noritoshi; Shiio, Yasushi; Uesaka, Yoshikazu; Hashida, Hideji; Iwata, Nobue K; Goto, Jun; Nakashima, Ran; Mimori, Tsuneyo; Toda, Tatsushi.
Afiliação
  • Kubota A; Department of Neurology, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Electronic address: akatsuki-tky@umin.net.
  • Shimizu J; Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; Department of Physical Therapy, Tokyo University of Technology, 5-25-8, Nishi-kamata, Ohta-ku, Tokyo 144-0051, Japan.
  • Unuma A; Department of Neurology, National Center of Neurology and Psychiatry, National Center Hospital, , 4-1-1, Ogawa-higashimachi, Kodaira-shi, Tokyo 187-8551, Japan.
  • Maeda M; Department of Neurology, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
  • Shirota Y; Department of Neurology, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
  • Kadoya M; Department of Neurology and Anti-aging Medicine, National Defense Medical College, 3-2, Namiki, Tokorozawa-shi, Saitama 359-8513, Japan.
  • Uchio N; Department of Neurology, Mitsui Memorial Hospital, 1 Kanda-izumicho, Chiyoda-ku, Tokyo 101-8643, Japan.
  • Sakiyama Y; Department of Neurology, Jichi Medical University Saitama Medical Center, 1-847, Amanuma-cho, Ohmiya-ku, Saitama-shi, Saitama 330-0834, Japan.
  • Arai N; Department of Neurology, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
  • Shiio Y; Department of Neurology, Tokyo Teishin Hospital, 2-14-23, Fujimi, Chiyoda-ku, Tokyo 102-0071, Japan.
  • Uesaka Y; Department of Neurology, Toranomon Hospital, 2-2-2, Toranomon, Minato-ku, Tokyo 105-8470, Japan.
  • Hashida H; Department of Neurology, Japanese Red Cross Medical Center, 4-1-22, Hiroo, Shibuya-ku, Tokyo 150-8935, Japan.
  • Iwata NK; Department of Neurology, International University of Health and Welfare Mita Hospital, 1-4-3, Mita, Minato-ku, Tokyo 108-8329, Japan.
  • Goto J; Department of Neurology, International University of Health and Welfare Mita Hospital, 1-4-3, Mita, Minato-ku, Tokyo 108-8329, Japan.
  • Nakashima R; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Yoshida-konoecho, Sakyo-ku, Kyoto-shi, Kyoto 606-8303, Japan.
  • Mimori T; Ijinkai Takeda General Hospital, Ishidamoriminamicho, Fushimi-ku, Kyoto-shi, Kyoto 601-1495, Japan.
  • Toda T; Department of Neurology, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Neuromuscul Disord ; 32(1): 25-32, 2022 01.
Article em En | MEDLINE | ID: mdl-34916121
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alanina Transaminase / Hidroximetilglutaril-CoA Redutases / Doenças Musculares Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neuromuscul Disord Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alanina Transaminase / Hidroximetilglutaril-CoA Redutases / Doenças Musculares Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neuromuscul Disord Ano de publicação: 2022 Tipo de documento: Article